CSIMarket
 
Taysha Gene Therapies Inc   (NASDAQ: TSHA)
 

Taysha Gene Therapies Inc's Customers Performance

TSHA



 
TSHA's Source of Revenues

List of TSHA Customers




for the same period Taysha Gene Therapies Inc

List of TSHA Customers





Taysha Gene Therapies Inc's Comment on Sales, Marketing and Customers





  News about Taysha Gene Therapies Inc Contracts

Taysha Gene Therapies: Advancing Rett Syndrome Clinical Program Amid Revenue Challenges

In recent updates revealed by Taysha Gene Therapies, the company announces significant progress in its TSHA-102 Clinical Program for Rett Syndrome. Additionally, the company reports a substantial decrease in revenue for the same period. This article aims to outline the facts surrounding these updates and assess their impact on Taysha Gene Therapies.Taysha Gene Therapies TSHA-102 Clinical Program Advancements:Taysha Gene Therapies has garnered attention for its groundbreaking gene therapy approach to treating Rett Syndrome, a rare neurological disorder affecting young girls. The company s latest announcement highlights the positive advancement of its REVEAL adolescent and adult trial, which has received appr...












TSHA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Taysha Gene Therapies Inc 1,871.05 8.10 -129.88 99
SUBTOTAL 0.00 0.00 0.00 -

Sources: Taysha Gene Therapies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Taysha Gene Therapies Inc’s corporate clients.
For your research, we’ve provided 9 tables on Taysha Gene Therapies Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.